SCHEMBL2900381

SCHEMBL2900381

COc1ccc(S(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.83
GAA P10253 1/20 0.68
HTR6 P50406 2/20 0.61
HTT P42858 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MMP2 P08253 5/20 0.57
MMP8 P22894 5/20 0.57
MMP13 P45452 5/20 0.57
MMP12 P39900 4/20 0.57
MMP14 P50281 4/20 0.57
MMP16 P51512 4/20 0.57
RAPGEF4 Q8WZA2 1/20 0.55
ALDH1A1 P00352 1/20 0.54
CA4 P22748 1/20 0.54
POLB P06746 1/20 0.54
HSD11B1 P28845 2/20 0.53
PGR P06401 1/20 0.53
MMP9 P14780 4/20 0.53
MMP1 P03956 2/20 0.53
MMP3 P08254 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15423745 0.94 PKM (0.73) PKMGAAHTR6HTTSMN1; SMN2
SCHEMBL20129486 0.94 PKM (0.73) PKMGAAHTR6HTTSMN1; SMN2
SCHEMBL13074716 0.91 PKM (1.00) PKMGAAHTTMMP2MMP8
SCHEMBL14486413 0.91 PKM (1.00) PKMGAAHTTMMP2MMP8
SCHEMBL835692 0.91 PKM (1.00) PKMGAAHTTMMP2MMP8
SCHEMBL10672859 0.90 HTT (0.73) PKMGAAHTTSMN1; SMN2MMP2
SCHEMBL10172900 0.89 PKM (0.66) PKMGAAHTR6HTTSMN1; SMN2
SCHEMBL12091354 0.89 PKM (0.66) PKMGAAHTTSMN1; SMN2MMP2
SCHEMBL7545245 0.87 PKM (0.61) PKMGAAHTTSMN1; SMN2MMP2
SCHEMBL9704374 0.86 PKM (0.61) PKMGAAHTR6HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650330-B2 Process for the synthesis of aryl sulfones COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-05-16 US claimed
US-20160304447-A1 A PROCESS FOR THE SYNTHESIS OF ARYL SULFONES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-10-20 US claimed
WO-2015087352-A1 A PROCESS FOR THE SYNTHESIS OF ARYL SULFONES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-06-18 WO claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
WO-2001083434-B1 P-(SULFONYL)-ARYL AND HETEROARYLS AMINES 2002-04-25 WO claimed
EP-3807090-B1 METHOD FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT USING A POLY(ARYL ETHER SULFONE) POLYMER AND A PER(HALO)FLUOROPOLYMER SOLVAY SPECIALTY POLYMERS USA (US) 2024-01-24 EP disclosed
EP-3972840-B1 ADDITIVE MANUFACTURING METHOD FOR MAKING A THREE-DIMENSIONAL OBJECT SOLVAY SPECIALTY POLYMERS USA (US) 2023-08-02 EP disclosed
CN-116496136-A Diaryl sulfone compound and preparation method thereof 华北水利水电大学 2023-07-28 CN disclosed
US-11685829-B2 Process for preparing particles of aromatic polymers, particles obtainable by said process and their uses SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2023-06-27 US disclosed
US-11654615-B2 Method for manufacturing a three-dimensional object SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2023-05-23 US disclosed
US-20230150930-A1 PHOTOCURABLE POLYMER COMPOSITIONS SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2023-05-18 US disclosed
US-4957925-A HYPOTENSIVE AGENTS, ANTIARRHYTHMIA AGENTS, TREATMENT OF ANGINA SANOFI (FR) 1990-09-18 US disclosed
US-4837301-A FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE BAYER AKTIENGESELLSCHAFT (DE) 1989-06-06 US disclosed
EP-0302792-A2 Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same SANOFI (FR) 1989-02-08 EP disclosed
EP-0302793-A2 Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same ELF SANOFI (FR) 1989-02-08 EP disclosed
EP-0275007-A2 Process for the preparation of highly molecular, optionally branched polyarylene sulfides BAYER AG (DE) 1988-07-20 EP disclosed
EP-0083204-A2 2-Aminophenol derivatives and process for their preparation ONO PHARMACEUTICAL CO., LTD. (JP) 1983-07-06 EP disclosed
EP-0081321-A1 2-Aminophenol derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1983-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150930-A1 PHOTOCURABLE POLYMER COMPOSITIONS ALG3, HTR3D, LCP1 PKM 1560/4885GAA 1970/4885HTR6 3015/4885
US-20160304447-A1 A PROCESS FOR THE SYNTHESIS OF ARYL SULFONES ARSA, TPST2, STS PKM 2141/4885GAA 423/4885HTR6 1035/4885
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 PKM 4493/4885GAA 4113/4885HTR6 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.